Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

for
Advanced Cancer, Metastatic Solid Tumor
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1 - 25

Code: NCT05004116

Phase 1, Phase 2, Recruiting

Young Breast Cancer Survivors Study

for
Breast Cancer
Location: Columbia SC
Sponsor: University of South Carolina

Sex: Female

Age: 18 - 60

Code: NCT05981716

Recruiting

Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

for
Metastatic Bladder Urothelial Carcinoma,
Location: Chicago IL, Orland Park IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06630416

Phase 2, Recruiting

Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial)

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06569316

Recruiting

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

for
Breast Cancer
Location: Boston MA, New York NY, Atlanta GA, Nashville TN,
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 18+

Code: NCT03990896

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Addressing Tetrachloroethylene Exposure in an Impacted Community

for
Vapors; Inhalation, Cancer, Volatile Organic Compounds
Location: West Lafayette IN
Sponsor: Purdue University

Sex: All

Age: 18 - 70+

Code: NCT05819996

Recruiting

Transportation for Cancer Care Navigation Tool for Reducing Travel Barriers Among Patients With Solid Tumors Receiving Radiation Therapy

for
Malignant Solid Neoplasm
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06541158

Recruiting

Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island

for
Breast Cancer, Colorectal Cancer, Covid19
Location: Pawtucket RI
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT04587258

Recruiting

Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

for
Solid, Liquid, Central Nervous System Tumors
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT02530658

Recruiting

High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

for
Breast Cancer
Location: Kansas City KS
Sponsor: Carol Fabian, MD

Sex: Female

Age: 30 - 65

Code: NCT00291096

Recruiting

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

for
Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05830058

Phase 2, Recruiting

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

for
Cancer
Location: New York NY, New Brunswick NJ, Philadelphia PA,
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT06014658

Phase 1, Phase 2, Recruiting

Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy

for
Adjuvant Radiotherapy for Breast Cancer
Location: Prince George, Surrey, Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT04257396

Recruiting

A Study of ASP1002 in Adults for Treatment of Solid Tumors

for
Advanced Solid Tumors
Location: Plainville CT, New Haven CT, New York NY, Fairfax VA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT05719558

Phase 1, Recruiting

Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer

for
Metastatic Breast Cancer, HER2-negative Breast Cancer
Location: Kansas City MO
Sponsor: Saint Luke's Health System

Sex: All

Age: 18 - 65

Code: NCT05025735

Phase 2, Recruiting

The Use of Indocyanine Green as a Diagnostic Adjunct for Pediatric Solid Malignancies

for
Metastatic Disease, Primary Tumor, Solid Malignancies
Location: Cincinnati OH
Sponsor: Roshni Dasgupta

Sex: All

Age: 0 - 45

Code: NCT04492735

Recruiting

Molecular Genetics Studies of Cancer Patients and Their Relatives

for
Malignant Neoplasm
Location: Brighton MA, Mount Kisco NY, Poughkeepsie NY,
Sponsor: City of Hope Medical Center

Sex: All

Age: 0+

Code: NCT04185935

Recruiting

Food and Microbiome Longitudinal Investigation (FAMiLI)

for
Cancer, Cardiovascular Diseases
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 40+

Code: NCT03293758

Recruiting

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06589596

Phase 1, Recruiting

Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy

for
Breast Cancer
Location: Quebec, Trois-Rivieres, Montreal,
Sponsor: Ontario Clinical Oncology Group (OCOG)

Sex: Female

Age: 50+

Code: NCT05866458

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial